{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:26:06Z","timestamp":1775262366698,"version":"3.50.1"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["IWT\/SBO130033"],"award-info":[{"award-number":["IWT\/SBO130033"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["IWT\/SBO130033"],"award-info":[{"award-number":["IWT\/SBO130033"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["IWT\/SBO130033"],"award-info":[{"award-number":["IWT\/SBO130033"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s40272-020-00401-7","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T02:03:26Z","timestamp":1591581806000},"page":"369-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pediatric Pharmacology of Desmopressin in Children with Enuresis: A Comprehensive Review"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-3560","authenticated-orcid":false,"given":"Elke","family":"Gasthuys","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lien","family":"Dossche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Michelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Peter","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Devreese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siska","family":"Croubels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Van Bocxlaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan Vande","family":"Walle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"issue":"7549","key":"401_CR1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S0140-6736(68)90904-5","volume":"1","author":"I V\u00e1vra","year":"1968","unstructured":"V\u00e1vra I, et al. Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus. Lancet. 1968;1(7549):948\u201352.","journal-title":"Lancet"},{"key":"401_CR2","doi-asserted-by":"crossref","unstructured":"Post EM, et al. Desmopressin response of enuretic children. Effects of age and frequency of enuresis. Am J Dis Child. 1983;137(10):962\u20133.","DOI":"10.1001\/archpedi.1983.02140360026009"},{"issue":"11\u201312","key":"401_CR3","first-page":"1047","volume":"26","author":"HL Ooi","year":"2013","unstructured":"Ooi HL, Maguire AM, Ambler GR. Desmopressin administration in children with central diabetes insipidus: a retrospective review. J Pediatr Endocrinol Metab. 2013;26(11\u201312):1047\u201352.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"401_CR4","first-page":"e16120","volume":"12","author":"K De Waele","year":"2014","unstructured":"De Waele K, et al. Desmopressin lyophilisate for the treatment of central diabetes insipidus: first experience in very young infants. Int J Endocrinol Metab. 2014;12(4):e16120.","journal-title":"Int J Endocrinol Metab"},{"key":"401_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2141.1975.tb00521.x","volume":"30","author":"PM Mannucci","year":"1975","unstructured":"Mannucci PM, et al. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol. 1975;30:81\u201393.","journal-title":"Br J Haematol"},{"issue":"8017","key":"401_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","volume":"1","author":"PM Mannucci","year":"1977","unstructured":"Mannucci PM, et al. 1-deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von willebrand\u2019s disease. Lancet. 1977;1(8017):869\u201372.","journal-title":"Lancet"},{"issue":"8","key":"401_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/adc.49.8.654","volume":"49","author":"AS Aronson","year":"1974","unstructured":"Aronson AS, Svenningsen NW. DDAVP test for estimation of renal concentrating capacity in infants and children. Arch Dis Child. 1974;49(8):654\u20139.","journal-title":"Arch Dis Child"},{"issue":"1","key":"401_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00000441-197801000-00004","volume":"275","author":"JP Rad\u00f3","year":"1978","unstructured":"Rad\u00f3 JP. 1-desamino-8-d-arginine vasopressin (DDAVP) concentration test. Am J Med Sci. 1978;275(1):43\u201352.","journal-title":"Am J Med Sci"},{"issue":"3","key":"401_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2174\/157488607781668891","volume":"2","author":"J Vande Walle","year":"2007","unstructured":"Vande Walle J, et al. Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf. 2007;2(3):232\u20138.","journal-title":"Curr Drug Saf"},{"key":"401_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.juro.2007.03.015","volume":"178","author":"WLM Robson","year":"2007","unstructured":"Robson WLM, Leung AKC, N\u00f8rgaard J-P. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. J Urol. 2007;178:24\u201330.","journal-title":"J Urol"},{"key":"401_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/11319110-000000000-00000","volume":"33","author":"JGJ Vande Walle","year":"2010","unstructured":"Vande Walle JGJ, Van Herzeele C, Raes A. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis? A focus on drug safety issues. Drug Saf. 2010;33:261\u201371.","journal-title":"Drug Saf"},{"key":"401_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s12325-015-0247-8","volume":"32","author":"A-S Goessaert","year":"2015","unstructured":"Goessaert A-S, et al. Pharmacokinetics and pharmacodynamics of the oral disintegrating tablet of desmopressin in adults with nocturnal polyuria: a pilot study. Adv Ther. 2015;32:799\u2013808.","journal-title":"Adv Ther"},{"key":"401_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1177\/0091270006291838","volume":"46","author":"O Osterberg","year":"2006","unstructured":"Osterberg O, et al. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults. J Clin Pharmacol. 2006;46:1204\u201311.","journal-title":"J Clin Pharmacol"},{"key":"401_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00431-013-2108-2","volume":"173","author":"P De Bruyne","year":"2014","unstructured":"De Bruyne P, et al. Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis. Eur J Pediatr. 2014;173:223\u20138.","journal-title":"Eur J Pediatr"},{"key":"401_CR15","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s40262-016-0393-4","volume":"55","author":"R Michelet","year":"2016","unstructured":"Michelet R, et al. Effects of food and pharmaceutical formulation on desmopressin pharmacokinetics in children. Clin Pharmacokinet. 2016;55:1159\u201370.","journal-title":"Clin Pharmacokinet"},{"key":"401_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fphar.2018.00041","volume":"9","author":"E Gasthuys","year":"2018","unstructured":"Gasthuys E, et al. Population pharmacokinetic modeling of a desmopressin oral lyophilisate in growing piglets as a model for the pediatric population. Front Pharmacol. 2018;9:41.","journal-title":"Front Pharmacol"},{"issue":"1","key":"401_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40262-019-00798-6","volume":"59","author":"R Michelet","year":"2020","unstructured":"Michelet R, et al. An integrated paediatric population PK\/PD analysis of dDAVP: how do PK differences translate to clinical outcomes? Clin Pharmacokinet. 2020;59(1):81\u201396.","journal-title":"Clin Pharmacokinet"},{"key":"401_CR18","doi-asserted-by":"crossref","unstructured":"Zaoral M, Kolc J, Sorm F. Amino acids and peptides. LXXI. Synthesis of 1-deamino-8-d-\u03b3-aminobutyrine-vasopressin, 1-deamino-8-d-lysine-vasopressin, and 1-deamino-8-d-arginine-vasopressin. Collect Czech Chem Commun. 1967;32:1250\u20137.","DOI":"10.1135\/cccc19671250"},{"key":"401_CR19","volume-title":"Progress in medicinal chemistry","author":"G Lawton","year":"2013","unstructured":"Lawton G, Witty DR. Progress in medicinal chemistry. Amsterdam: Elsevier; 2013."},{"key":"401_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/bmj.3.5876.375","volume":"3","author":"CRW Edwards","year":"1973","unstructured":"Edwards CRW, Kitau MJ, Besser GM. Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J. 1973;3:375\u20138.","journal-title":"Br Med J"},{"issue":"10","key":"401_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJM197603042941001","volume":"294","author":"AG Robinson","year":"1976","unstructured":"Robinson AG. DDAVP in the treatment of central diabetes insipidus. N Engl J Med. 1976;294(10):507\u201311.","journal-title":"N Engl J Med"},{"issue":"6","key":"401_CR22","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/S0022-5347(05)65608-X","volume":"166","author":"SL Schulman","year":"2001","unstructured":"Schulman SL, Stokes A, Salzman PM. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. J Urol. 2001;166(6):2427\u201331.","journal-title":"J Urol"},{"issue":"12","key":"401_CR23","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1091\/mbc.e04-04-0337","volume":"15","author":"JH Robben","year":"2004","unstructured":"Robben JH, Knoers NVAM, Deen PMT. Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells. Mol Biol Cell. 2004;15(12):5693\u20139.","journal-title":"Mol Biol Cell"},{"key":"401_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.108.765289","volume":"118","author":"JJ Finley","year":"2008","unstructured":"Finley JJ, Marvin A, Udelson JE. Arginine vasopressin antagonists for the treatment of heart failure and hyponatremia. Circulation. 2008;118:410\u201321.","journal-title":"Circulation"},{"issue":"4","key":"401_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/nau.22751","volume":"35","author":"PF Austin","year":"2016","unstructured":"Austin PF, et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children's Continence Society. Neurourol Urodyn. 2016;35(4):471\u201381.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"401_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0022-5347(06)00305-3","volume":"176","author":"T Nev\u00e9us","year":"2006","unstructured":"Nev\u00e9us T, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol. 2006;176(1):314\u201324.","journal-title":"J Urol"},{"issue":"10","key":"401_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/pch\/10.10.611","volume":"10","author":"Canadian Pediatric Society","year":"2005","unstructured":"Canadian Pediatric Society. Management of primary nocturnal enuresis. Paediatr Child Health. 2005;10(10):611\u20134.","journal-title":"Paediatr Child Health"},{"issue":"2","key":"401_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.urology.2009.11.078","volume":"76","author":"BS Buckley","year":"2010","unstructured":"Buckley BS, et al. Prevalence of urinary incontinence in men, women, and children\u2013current evidence: findings of the fourth international consultation on incontinence. Urology. 2010;76(2):265\u201370.","journal-title":"Urology"},{"issue":"4","key":"401_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5527\/wjn.v5.i4.328","volume":"5","author":"R Sinha","year":"2016","unstructured":"Sinha R, Raut S. Management of nocturnal enuresis - myths and facts. World J Nephrol. 2016;5(4):328\u201338.","journal-title":"World J Nephrol"},{"issue":"5","key":"401_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s004670050186","volume":"10","author":"SA Koff","year":"1996","unstructured":"Koff SA. Cure of nocturnal enuresis: why isn't desmopressin very effective? Pediatr Nephrol. 1996;10(5):667\u201370.","journal-title":"Pediatr Nephrol"},{"key":"401_CR31","doi-asserted-by":"crossref","unstructured":"Forsythe WI, Redmond A. Enuresis and spontaneous cure rate. Study of 1129 enuretis. Arch Dis Child. 1974;49(4):259\u201363.","DOI":"10.1136\/adc.49.4.259"},{"issue":"6","key":"401_CR32","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0302-2838(02)00127-6","volume":"41","author":"M Theunis","year":"2002","unstructured":"Theunis M, et al. Self-image and performance in children with nocturnal enuresis. Eur Urol. 2002;41(6):660\u20137.","journal-title":"Eur Urol"},{"issue":"Suppl 3","key":"401_CR33","first-page":"16","volume":"33","author":"B Hagglof","year":"1998","unstructured":"Hagglof B, et al. Self-esteem in children with nocturnal enuresis and urinary incontinence: improvement of self-esteem after treatment. Eur Urol. 1998;33(Suppl 3):16\u20139.","journal-title":"Eur Urol"},{"issue":"2","key":"401_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00467-016-3376-7","volume":"32","author":"K Kamperis","year":"2017","unstructured":"Kamperis K, et al. Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis. Pediatr Nephrol. 2017;32(2):217\u201326.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"401_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.gtc.2008.06.007","volume":"37","author":"RJM Nijman","year":"2008","unstructured":"Nijman RJM. Diagnosis and management of urinary incontinence and functional fecal incontinence (encopresis) in children. Gastroenterol Clin North Am. 2008;37(3):731\u201348.","journal-title":"Gastroenterol Clin North Am."},{"key":"401_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1365-2265.1998.00340.x","volume":"48","author":"S Rittig","year":"1998","unstructured":"Rittig S, et al. Effect of food intake on the pharmacokinetic and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects. Clin Endocrinol. 1998;48:235\u201341.","journal-title":"Clin Endocrinol"},{"key":"401_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1464-410X.2006.05999.x","volume":"97","author":"JGJ Vande Walle","year":"2006","unstructured":"Vande Walle JGJ, et al. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int. 2006;97:603\u20139.","journal-title":"BJU Int"},{"key":"401_CR38","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.juro.2008.09.040","volume":"181","author":"A De Guchtenaere","year":"2009","unstructured":"De Guchtenaere A, et al. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray. J Urol. 2009;181:302\u20139.","journal-title":"J Urol"},{"issue":"4 Suppl","key":"401_CR39","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.juro.2009.03.068","volume":"182","author":"D Marschall-Kehrel","year":"2009","unstructured":"Marschall-Kehrel D, Harms TW. Structured desmopressin withdrawal improves response and treatment outcome for monosymptomatic enuretic children. J Urol. 2009;182(4 Suppl):2022\u20136.","journal-title":"J Urol"},{"issue":"4","key":"401_CR40","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/ped.12614","volume":"57","author":"Y Ohtomo","year":"2015","unstructured":"Ohtomo Y, et al. Gradual tapering of desmopressin leads to better outcome in nocturnal enuresis. Pediatr Int. 2015;57(4):656\u20138.","journal-title":"Pediatr Int"},{"issue":"1","key":"401_CR41","doi-asserted-by":"publisher","first-page":"e20160495","DOI":"10.1542\/peds.2016-0495","volume":"138","author":"ME Chua","year":"2016","unstructured":"Chua ME, et al. Desmopressin withdrawal strategy for pediatric enuresis: a meta-analysis. Pediatrics. 2016;138(1):e20160495.","journal-title":"Pediatrics."},{"key":"401_CR42","first-page":"335","volume":"102","author":"RA Dalrymple","year":"2017","unstructured":"Dalrymple RA, Wacogne ID. Gradual withdrawal of desmopressin in patients with enuresis leads to fewer relapses than an abrupt withdrawal. Arch Dis Child Educ Pract Ed. 2017;102:335.","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"1","key":"401_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1017\/S146342361300042X","volume":"16","author":"N Perrin","year":"2015","unstructured":"Perrin N, Sayer L, While A. The efficacy of alarm therapy versus desmopressin therapy in the treatment of primary mono-symptomatic nocturnal enuresis: a systematic review. Prim Health Care Res Dev. 2015;16(1):21\u201331.","journal-title":"Prim Health Care Res Dev"},{"key":"401_CR44","doi-asserted-by":"crossref","unstructured":"Peng CC, et al. Systematic review and meta-analysis of alarm versus desmopressin therapy for pediatric monosymptomatic enuresis. Sci Rep. 2018; 8(1):16755.","DOI":"10.1038\/s41598-018-34935-1"},{"issue":"1","key":"401_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jpurol.2010.04.018","volume":"7","author":"J Evans","year":"2011","unstructured":"Evans J, et al. Randomized comparison of long-term desmopressin and alarm treatment for bedwetting. J Pediatr Urol. 2011;7(1):21\u20139.","journal-title":"J Pediatr Urol"},{"issue":"2","key":"401_CR46","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.juro.2014.08.088","volume":"193","author":"FF \u00d6nol","year":"2015","unstructured":"\u00d6nol FF, et al. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial. J Urol. 2015;193(2):655\u201361.","journal-title":"J Urol"},{"issue":"3","key":"401_CR47","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/bju.14539","volume":"123","author":"P Song","year":"2019","unstructured":"Song P, et al. Comparison of desmopressin, alarm, desmopressin plus alarm, and desmopressin plus anticholinergic agents in the management of paediatric monosymptomatic nocturnal enuresis: a network meta-analysis. BJU Int. 2019;123(3):388\u2013400.","journal-title":"BJU Int"},{"issue":"3","key":"401_CR48","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/01.ju.0000169160.84418.15","volume":"174","author":"T Lee","year":"2005","unstructured":"Lee T, et al. Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial. J Urol. 2005;174(3):1084\u20137.","journal-title":"J Urol"},{"issue":"3","key":"401_CR49","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.urology.2005.03.022","volume":"66","author":"Y Naitoh","year":"2005","unstructured":"Naitoh Y, et al. Combination therapy with alarm and drugs for monosymptomatic nocturnal enuresis not superior to alarm monotherapy. Urology. 2005;66(3):632\u20135.","journal-title":"Urology"},{"issue":"6","key":"401_CR50","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.juro.2007.08.026","volume":"178","author":"A De Guchtenaere","year":"2007","unstructured":"De Guchtenaere A, et al. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning. J Urol. 2007;178(6):2635\u20139.","journal-title":"J Urol"},{"issue":"12","key":"401_CR51","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/j.1464-410X.2008.08285.x","volume":"103","author":"SH Alloussi","year":"2009","unstructured":"Alloussi SH, et al. Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes. BJU Int. 2009;103(12):1706\u201312.","journal-title":"BJU Int"},{"key":"401_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.urology.2018.09.013","volume":"124","author":"M Jabbour","year":"2019","unstructured":"Jabbour M, Abou Zahr R, Boustany M. Primary nocturnal enuresis: a novel therapeutic strategy with higher efficacy. Urology. 2019;124:241\u20137.","journal-title":"Urology"},{"issue":"7","key":"401_CR53","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00467-014-2751-5","volume":"29","author":"SJ Park","year":"2014","unstructured":"Park SJ, et al. Desmopressin alone versus desmopressin and an anticholinergic in the first-line treatment of primary monosymptomatic nocturnal enuresis: a multicenter study. Pediatr Nephrol. 2014;29(7):1195\u2013200.","journal-title":"Pediatr Nephrol"},{"key":"401_CR54","doi-asserted-by":"crossref","unstructured":"Radvanska E, Kov\u00e1cs L, Rittig S. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis. J Urol 2006;176(2):764\u20138 (discussion 768\u20139).","DOI":"10.1016\/S0022-5347(06)00595-7"},{"issue":"3","key":"401_CR55","first-page":"80","volume":"4","author":"A Azarfar","year":"2015","unstructured":"Azarfar A, et al. Comparison of combined treatment with desmopressin plus oxybutynin and desmopressin plus tolterodine in treatment of children with primary nocturnal enuresis. J Renal Inj Prev. 2015;4(3):80\u20136.","journal-title":"J Renal Inj Prev"},{"issue":"4","key":"401_CR56","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00467-016-3536-9","volume":"32","author":"K Kamperis","year":"2017","unstructured":"Kamperis K, et al. Combination treatment of nocturnal enuresis with desmopressin and indomethacin. Pediatr Nephrol. 2017;32(4):627\u201333.","journal-title":"Pediatr Nephrol"},{"key":"401_CR57","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00228-003-0682-3","volume":"59","author":"C Joukhadar","year":"2003","unstructured":"Joukhadar C, et al. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations. Eur J Clin Pharmacol. 2003;59:631\u20136.","journal-title":"Eur J Clin Pharmacol"},{"key":"401_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1542\/peds.103.1.65","volume":"103","author":"T Nev\u00e9us","year":"1999","unstructured":"Nev\u00e9us T, et al. Osmoregulation and desmopressin pharmacokinetics in enuretic children. Pediatric. 1999;103:65\u201370.","journal-title":"Pediatric"},{"key":"401_CR59","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1530\/acta.0.1120457","volume":"112","author":"S Lundin","year":"1986","unstructured":"Lundin S, Vilhardt H. Absorption of 1-deamino-8-d-arginine from different regions of the gastrointestinal tract in rabbits. Acta Endocrinol. 1986;112:457\u201360.","journal-title":"Acta Endocrinol"},{"issue":"5","key":"401_CR60","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/BF00315546","volume":"44","author":"L d'Agay-Abensour","year":"1993","unstructured":"d'Agay-Abensour L, et al. Absolute bioavailability of an aqueous solution of 1-deamino-8-d-arginine vasopressin from different regions of the gastrointestinal tract in man. Eur J Clin Pharmacol. 1993;44(5):473\u20136.","journal-title":"Eur J Clin Pharmacol"},{"key":"401_CR61","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2265.1993.tb00990.x","volume":"38","author":"A Fjellstad-Paulsen","year":"1993","unstructured":"Fjellstad-Paulsen A, et al. Pharmacokinetics of 1-deamino-8-d-arginine vasopressin after various routes of administration in healthy volunteers. Clin Endocrinol. 1993;38:177\u201382.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"401_CR62","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00228-017-2386-0","volume":"74","author":"R Michelet","year":"2018","unstructured":"Michelet R, et al. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis. Eur J Clin Pharmacol. 2018;74(3):297\u2013305.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"401_CR63","doi-asserted-by":"publisher","first-page":"434","DOI":"10.5414\/CP203241","volume":"56","author":"X Li","year":"2018","unstructured":"Li X, et al. Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditions. Int J Clin Pharmacol Ther. 2018;56(9):434\u201342.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"401_CR64","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s002280050633","volume":"55","author":"T Callr\u00e9us","year":"1999","unstructured":"Callr\u00e9us T, et al. Changes in gastrointestinal motility influence the absorption of desmopressin. Eur J Clin Pharmacol. 1999;55:305\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"401_CR65","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1211\/0022357044535","volume":"56","author":"JM Odeberg","year":"2004","unstructured":"Odeberg JM, et al. A pharmacokinetic and pharmacodynamic study of desmopressin : evaluating sex differences and the effect of pre-treatment of piroxicam, and further validation of an indirect response model. J Pharm Pharmacol. 2004;56:1389\u201398.","journal-title":"J Pharm Pharmacol"},{"key":"401_CR66","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00228-004-0781-9","volume":"60","author":"A Rembratt","year":"2004","unstructured":"Rembratt A, et al. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55\u201370 years. Eur J Clin Pharmacol. 2004;60:397\u2013402.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"401_CR67","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2362.1984.tb01209.x","volume":"14","author":"PS S\u00f8rensen","year":"1984","unstructured":"S\u00f8rensen PS, et al. Impermeability of the blood-cerebrospinal fluid barrier to 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus. Eur J Clin Invest. 1984;14(6):435\u20139.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"401_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/acta.0.0970023","volume":"97","author":"GN Burrow","year":"1981","unstructured":"Burrow GN, et al. DDAVP treatment of diabetes insipidus during pregnancy and the post-partum period. Acta Endocrinol (Copenh). 1981;97(1):23\u20135.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"401_CR69","volume-title":"Antidiuretic hormone","author":"K Shimizu","year":"1980","unstructured":"Shimizu K, et al. Antidiuretic hormone. Tokyo: University Pack Press; 1980."},{"issue":"1","key":"401_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0167-0115(96)00103-6","volume":"67","author":"A Fjellstad-Paulsen","year":"1996","unstructured":"Fjellstad-Paulsen A, Lundin S. Metabolism of vasopressin, oxytocin and their analogues [Mpa1, d-Arg8]-vasopressin (dDAVP) and [Mpa1, d-Tyr(Et)2, Thr4, Orn8]-oxytocin (antocin) in human kidney and liver homogenates. Regul Pept. 1996;67(1):27\u2013322.","journal-title":"Regul Pept"},{"key":"401_CR71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1600-0773.1991.tb01218.x","volume":"68","author":"S Lundin","year":"1991","unstructured":"Lundin S, et al. Biliary excretion of the vasopressin analogue DDAVP after intraduodenal, intrajugular and intraportal administration in the conscious pig. Pharm Tox. 1991;68:177\u201380.","journal-title":"Pharm Tox"},{"issue":"6","key":"401_CR72","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/0196-9781(95)00088-2","volume":"16","author":"A Fjellstad-Paulsen","year":"1995","unstructured":"Fjellstad-Paulsen A, S\u00f6derberg-Ahlm C, Lundin S. Metabolism of vasopressin, oxytocin, and their analogues in the human gastrointestinal tract. Peptides. 1995;16(6):1141\u20137.","journal-title":"Peptides"},{"key":"401_CR73","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s002280050146","volume":"50","author":"A Fjellstad-Paulsen","year":"1996","unstructured":"Fjellstad-Paulsen A, et al. Bioavailability of 1-deamino-8-d-arginine vasopressin with an enzyme inhibitor (aprotinin) from the small intestine in healthy volunteers. Eur J Clin Pharmacol. 1996;50:491\u20135.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"401_CR74","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2125.2004.02175.x","volume":"58","author":"H Agerso","year":"2004","unstructured":"Agerso H, et al. Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients. Br J Clin Pharm. 2004;58(4):352\u20138.","journal-title":"Br J Clin Pharm"},{"issue":"1","key":"401_CR75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/00003495-200565010-00008","volume":"65","author":"RS Cvetkovic","year":"2005","unstructured":"Cvetkovic RS, Plosker GL. Desmopressin in adults with nocturia. Drugs. 2005;65(1):99\u2013107.","journal-title":"Drugs"},{"key":"401_CR76","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2125.1996.39914.x","volume":"42","author":"KSL Lam","year":"1996","unstructured":"Lam KSL, et al. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-d-arginine vasopressin in adult patients with central diabetes insipidus. Br J Clin Pharmacol. 1996;42:379\u201385.","journal-title":"Br J Clin Pharmacol"},{"key":"401_CR77","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1464-410X.2005.05405.x","volume":"95","author":"GM Hvistendahl","year":"2004","unstructured":"Hvistendahl GM, et al. The pharmacokinetics of 400 \u00b5g of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect. BJU Int. 2004;95:804\u20139.","journal-title":"BJU Int"},{"key":"401_CR78","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000092625","volume":"77","author":"ST Kaehler","year":"2006","unstructured":"Kaehler ST, et al. A bioequivalence study of two oral desmopressin tablet formulations. Pharmacology. 2006;77:46\u201352.","journal-title":"Pharmacology"},{"key":"401_CR79","doi-asserted-by":"crossref","unstructured":"Williams TD, et al. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-d-arginine vasopressin. 1. Studies in adults and children. J Clin Endocrinol Metab. 1986;63(1):129\u201332.","DOI":"10.1210\/jcem-63-1-129"},{"key":"401_CR80","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/S0022-5347(05)66325-2","volume":"165","author":"D Argenti","year":"2001","unstructured":"Argenti D, Ireland D, Heald DL. A pharmacokinetic and pharmacodynamics comparison of desmopressin administered as whole, chewed and crushed tablets, and as an oral solution. J Urol. 2001;165:1446\u2013511.","journal-title":"J Urol"},{"issue":"4","key":"401_CR81","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5414\/CPP44172","volume":"44","author":"IM Steiner","year":"2006","unstructured":"Steiner IM, et al. Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers. Int J Clin Pharm Therp. 2006;44(4):172\u20139.","journal-title":"Int J Clin Pharm Therp"},{"issue":"7","key":"401_CR82","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s11095-009-9871-9","volume":"26","author":"N Frans\u00e9n","year":"2009","unstructured":"Frans\u00e9n N, Bredenberg S, Bj\u00f6rk E. Clinical study shows improved absorption of desmopressin with novel formulation. Pharmaceut Res. 2009;26(7):1618\u201325.","journal-title":"Pharmaceut Res"},{"issue":"3","key":"401_CR83","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1034\/j.1600-0773.2003.920306.x","volume":"92","author":"H Ruzicka","year":"2003","unstructured":"Ruzicka H, et al. Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failure. Pharmacol Toxicol. 2003;92(3):137\u201342.","journal-title":"Pharmacol Toxicol"},{"key":"401_CR84","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1651-2227.1988.tb10614.x","volume":"77","author":"MR J\u00e4rvelin","year":"1988","unstructured":"J\u00e4rvelin MR, et al. Enuresis in seven-year-old children. Acta Paediatr Scand. 1988;77:148\u201353.","journal-title":"Acta Paediatr Scand"},{"issue":"1 suppl","key":"401_CR85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/0009922893032001S05","volume":"32","author":"K Hj\u00e4lm\u00e5s","year":"1993","unstructured":"Hj\u00e4lm\u00e5s K, Bengtsson B. Efficacy, safety and dosing of desmopressin for nocturnal enuresis in Europe. Clin Pediatr (Phila). 1993;32(1 suppl):19\u201324.","journal-title":"Clin Pediatr (Phila)."},{"key":"401_CR86","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0022-5347(01)67385-3","volume":"153","author":"J-P N\u00f8rgaard","year":"1995","unstructured":"N\u00f8rgaard J-P, et al. A pharmacodynamic study of desmopressin in patients with nocturnal enuresis. J Urol. 1995;153:1984\u20136.","journal-title":"J Urol"},{"issue":"1","key":"401_CR87","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-5347(17)48785-4","volume":"133","author":"PS Pedersen","year":"1985","unstructured":"Pedersen PS, Hejl M, Kj\u00f8ller SS. Desamino-d-arginine vasopressin in childhood nocturnal enuresis. J Urol. 1985;133(1):65\u20136.","journal-title":"J Urol"},{"key":"401_CR88","doi-asserted-by":"crossref","unstructured":"Hj\u00e4lm\u00e5s K, et al. Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group. Br J Urol. 1998;82(5):704\u20139.","DOI":"10.1046\/j.1464-410X.1998.00826.x"},{"issue":"Suppl 3","key":"401_CR89","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1046\/j.1464-410x.1998.0810s3017.x","volume":"81","author":"G L\u00e4ckgren","year":"1998","unstructured":"L\u00e4ckgren G, et al. Desmopressin in the treatment of severe nocturnal enuresis in adolescents\u2013a 7-year follow-up study. Br J Urol. 1998;81(Suppl 3):17\u201323.","journal-title":"Br J Urol"},{"issue":"9","key":"401_CR90","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1046\/j.1464-410X.2002.02788.x","volume":"89","author":"GM Hvistendahl","year":"2002","unstructured":"Hvistendahl GM, et al. The relationship between desmopressin treatment and voiding pattern in children. BJU Int. 2002;89(9):917\u201322.","journal-title":"BJU Int"},{"issue":"1","key":"401_CR91","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/00365590310008631","volume":"37","author":"NM Wolfish","year":"2003","unstructured":"Wolfish NM, et al. The Canadian Enuresis Study and Evaluation\u2013short- and long-term safety and efficacy of an oral desmopressin preparation. Scand J Urol Nephrol. 2003;37(1):22\u20137.","journal-title":"Scand J Urol Nephrol"},{"issue":"1","key":"401_CR92","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1742-1241.2008.01956.x","volume":"63","author":"H Lottmann","year":"2009","unstructured":"Lottmann H, et al. Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study. Int J Clin Pract. 2009;63(1):35\u201345.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"401_CR93","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1055\/s-0042-107889","volume":"47","author":"S Schulz-J\u00fcrgensen","year":"2016","unstructured":"Schulz-J\u00fcrgensen S, Feldmann B, Eggert P. Desmopressin in the treatment of enuresis: Is lyophilisate superior to tablets? Aktuelle Urol. 2016;47(6):480\u20136.","journal-title":"Aktuelle Urol"},{"issue":"6","key":"401_CR94","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.juro.2011.02.039","volume":"185","author":"A De Guchtenaere","year":"2011","unstructured":"De Guchtenaere A, et al. Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction. J Urol. 2011;185(6):2308\u201313.","journal-title":"J Urol"},{"issue":"9","key":"401_CR95","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1742-1241.2007.01493.x","volume":"61","author":"H Lottmann","year":"2007","unstructured":"Lottmann H, et al. A randomized comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis. Int J Clin Pract. 2007;61(9):1454\u201360.","journal-title":"Int J Clin Pract"},{"issue":"9","key":"401_CR96","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00431-013-1992-9","volume":"172","author":"KV Juul","year":"2013","unstructured":"Juul KV, et al. Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis. Eur J Pediatr. 2013;172(9):1235\u201342.","journal-title":"Eur J Pediatr"},{"key":"401_CR97","first-page":"1","volume":"140","author":"J-P N\u00f8rgaard","year":"1991","unstructured":"N\u00f8rgaard J-P. Pathophysiology of nocturnal enuresis. Scand J Urol Nephrol. 1991;140:1\u201335.","journal-title":"Scand J Urol Nephrol"},{"issue":"1","key":"401_CR98","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5152\/tud.2018.03285","volume":"44","author":"P Ferrara","year":"2018","unstructured":"Ferrara P, et al. The adverse effects of oral desmopressin lyophilisate (MELT): personal experience on enuretic children. Turk J Urol. 2018;44(1):51\u20135.","journal-title":"Turk J Urol"},{"key":"401_CR99","doi-asserted-by":"crossref","unstructured":"Glazener CMA, Evans JHC. Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev 2002;(3):CD002112.","DOI":"10.1002\/14651858.CD002112"},{"key":"401_CR100","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/003655999750016285-1","volume":"202","author":"J-P N\u00f8rgaard","year":"1999","unstructured":"N\u00f8rgaard J-P. A clinical and pharmacological model for explaining response to desmopressin. Scand J Urol Nephrol. 1999;202:53\u20135.","journal-title":"Scand J Urol Nephrol"},{"issue":"2","key":"401_CR101","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0022-5347(01)65775-6","volume":"156","author":"HG Rushton","year":"1996","unstructured":"Rushton HG, et al. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis. J Urol. 1996;156(2):651\u20135.","journal-title":"J Urol"},{"issue":"2 Pt 1","key":"401_CR102","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0022-5347(17)35506-4","volume":"150","author":"RJ Hogg","year":"1993","unstructured":"Hogg RJ, Husmann D. he role of family history in predicting response to desmopressin in nocturnal enuresis. J Urol. 1993;150(2 Pt 1):444\u20135.","journal-title":"J Urol"},{"issue":"6","key":"401_CR103","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/S0022-5347(05)65610-8","volume":"166","author":"HL Schaumburg","year":"2001","unstructured":"Schaumburg HL, Rittig S, Djurhuus JC. No relationship between family history of enuresis and response to desmopressin. J Urol. 2001;166(6):2435\u20137.","journal-title":"J Urol"},{"issue":"5","key":"401_CR104","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/adc.80.5.448","volume":"80","author":"H Devitt","year":"1999","unstructured":"Devitt H, et al. Plasma vasopressin and response to treatment in primary nocturnal enuresis. Arch Dis Child. 1999;80(5):448\u201351.","journal-title":"Arch Dis Child"},{"issue":"6","key":"401_CR105","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1464-410X.2001.02321.x","volume":"88","author":"S Kruse","year":"2001","unstructured":"Kruse S, et al. Treatment of primary monosymptomatic nocturnal enuresis with desmopressin: predictive factors. BJU Int. 2001;88(6):572\u20136.","journal-title":"BJU Int"},{"issue":"4","key":"401_CR106","doi-asserted-by":"publisher","first-page":"200.e1","DOI":"10.1016\/j.jpurol.2015.03.007","volume":"11","author":"C Van Herzeele","year":"2015","unstructured":"Van Herzeele C, et al. Predictive parameters of response to desmopressin in primary nocturnal enuresis. J Pediatr Urol. 2015;11(4):200.e1\u20138.","journal-title":"J Pediatr Urol"},{"issue":"4 Suppl","key":"401_CR107","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.juro.2009.06.001","volume":"182","author":"C Van Herzeele","year":"2009","unstructured":"Van Herzeele C, et al. Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response. J Urol. 2009;182(4 Suppl):2045\u20139.","journal-title":"J Urol"},{"key":"401_CR108","doi-asserted-by":"publisher","first-page":"F116","DOI":"10.1152\/ajprenal.00741.2010","volume":"300","author":"KV Juul","year":"2011","unstructured":"Juul KV, et al. Gender difference in antidiuretic response to desmopressin. Am J Physiol Renal Physiol. 2011;300:F116\u2013F12222.","journal-title":"Am J Physiol Renal Physiol"},{"key":"401_CR109","doi-asserted-by":"publisher","first-page":"F433","DOI":"10.1152\/ajprenal.00199.2010","volume":"300","author":"J Liu","year":"2011","unstructured":"Liu J, et al. Sex differences in vasopressin V2 receptor expression, and vasopressin-induced antidiuresis. Am J Physiol Renal Physiol. 2011;300:F433\u2013F440440.","journal-title":"Am J Physiol Renal Physiol"},{"key":"401_CR110","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature03479","volume":"434","author":"L Carrel","year":"2005","unstructured":"Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005;434:400\u20134.","journal-title":"Nature"},{"issue":"3","key":"401_CR111","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00431-017-3074-x","volume":"177","author":"MK Schroeder","year":"2018","unstructured":"Schroeder MK, et al. Desmopressin use in pediatric nocturnal enuresis patients: is there a sex difference in prescription patterns? Eur J Pediatr. 2018;177(3):389\u201394.","journal-title":"Eur J Pediatr"},{"issue":"7","key":"401_CR112","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/adc.62.7.674","volume":"62","author":"A Fjellstad-Paulsen","year":"1987","unstructured":"Fjellstad-Paulsen A, Wille S, Harris AS. Comparison of intranasal and oral desmopressin for nocturnal enuresis. Arch Dis Child. 1987;62(7):674\u20137.","journal-title":"Arch Dis Child"},{"issue":"3","key":"401_CR113","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0165-5876(01)00431-1","volume":"58","author":"S Li Volti","year":"2001","unstructured":"Li Volti S, et al. The nasal mucosa of children with nocturnal enuresis before and after treatment with 1-deamino 8-d-arginine vasopressin spray. Int J Pediatr Otorhinolaryngol. 2001;58(3):211\u20134.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"11","key":"401_CR114","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.ijporl.2006.06.019","volume":"70","author":"E Ako\u011flu","year":"2006","unstructured":"Ako\u011flu E, et al. Effect of 1-deamino 8-d-arginine vasopressin spray on nasal cytology and mucociliary clearance in patients with nocturnal enuresis. Int J Pediatr Otorhinolaryngol. 2006;70(11):1919\u201322.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"10","key":"401_CR115","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1651-2227.2002.tb00109.x","volume":"91","author":"T Nev\u00e9us","year":"2002","unstructured":"Nev\u00e9us T, Bader G, Sill\u00e9n U. Enuresis, sleep and desmopressin treatment. Acta Paediatr. 2002;91(10):1121\u20135.","journal-title":"Acta Paediatr"},{"key":"401_CR116","doi-asserted-by":"crossref","unstructured":"Dehoorne JL, et al. Desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis. J Urol. 2006;176(2):754\u20137 (discussion 757\u20138).","DOI":"10.1016\/S0022-5347(06)00299-0"},{"key":"401_CR117","doi-asserted-by":"crossref","unstructured":"Thumfart J, et al. Desmopressin associated symptomatic hyponatremic hypervolemia in children. Are there predictive factors? J Urol. 2005;174(1):294\u20138 (discussion 298).","DOI":"10.1097\/01.ju.0000161213.54024.7f"},{"key":"401_CR118","doi-asserted-by":"crossref","unstructured":"Lucchini B, et al. Severe signs of hyponatremia secondary to desmopressin treatment for enuresis: a systematic review. J Pediatr Urol. 2013;9(6 Pt B):1049\u201353.","DOI":"10.1016\/j.jpurol.2013.02.012"},{"issue":"4","key":"401_CR119","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/00365590410018729","volume":"39","author":"R Del Gado","year":"2005","unstructured":"Del Gado R, et al. Desmopressin is a safe drug for the treatment of enuresis. Scand J Urol Nephrol. 2005;39(4):308\u201312.","journal-title":"Scand J Urol Nephrol"},{"issue":"8","key":"401_CR120","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00467-006-0137-z","volume":"21","author":"K Kano","year":"2006","unstructured":"Kano K, Arisaka O. Efficacy and safety of nasal desmopressin in the long-term treatment of primary nocturnal enuresis. Pediatr Nephrol. 2006;21(8):1211.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"401_CR121","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF00305302","volume":"19","author":"UB Knudsen","year":"1991","unstructured":"Knudsen UB, et al. Long-term treatment of nocturnal enuresis with desmopressin. A follow-up study. Urol Res. 1991;19(4):237\u201340.","journal-title":"Urol Res"},{"issue":"1","key":"401_CR122","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jpurol.2010.04.014","volume":"7","author":"SH Alloussi","year":"2011","unstructured":"Alloussi SH, et al. Desmopressin treatment regimens in monosymptomatic and nonmonosymptomatic enuresis: A review from a clinical perspective. J Pediatr Urol. 2011;7(1):10\u201320.","journal-title":"J Pediatr Urol"},{"issue":"3","key":"401_CR123","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/archpedi.152.3.290","volume":"152","author":"MB Donoghue","year":"1998","unstructured":"Donoghue MB, et al. Hyponatremic seizure in a child using desmopressin for nocturnal enuresis. Arch Pediatr Adolesc Med. 1998;152(3):290\u20132.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"401_CR124","doi-asserted-by":"crossref","unstructured":"Beach PS, Beach RE, Smith LR. Hyponatremic seizures in a child treated with desmopressin to control enuresis. A rational approach to fluid intake. Clin Pediatr (Phila) 1992;31(9):566\u20139.","DOI":"10.1177\/000992289203100913"},{"issue":"7","key":"401_CR125","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/PEC.0b013e3181e5bf9e","volume":"26","author":"S Boetzkes","year":"2010","unstructured":"Boetzkes S, et al. Two unusual pediatric cases of dilutional hyponatremia. Pediatr Emerg Care. 2010;26(7):503\u20135.","journal-title":"Pediatr Emerg Care"},{"issue":"12","key":"401_CR126","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1007\/s12325-014-0173-1","volume":"31","author":"C Van Herzeele","year":"2014","unstructured":"Van Herzeele C, et al. Safety profile of desmopressin tablet for enuresis in a prospective study. Adv Ther. 2014;31(12):1306\u201316.","journal-title":"Adv Ther"},{"issue":"2","key":"401_CR127","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4081\/aiua.2018.2.127","volume":"90","author":"P Ferrara","year":"2018","unstructured":"Ferrara P, et al. Desmopressin 120 mcg, 180 mcg, 240 mcg: the right treatment for the right patient. Arch Ital Urol Androl. 2018;90(2):127\u20139.","journal-title":"Arch Ital Urol Androl"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-020-00401-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-020-00401-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-020-00401-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T23:49:26Z","timestamp":1623109766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-020-00401-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1007\/s40272-020-00401-7","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"8 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Elke Gasthuys, Lien Dossche and Robin Michelet were supported by a doctoral fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT) through the \u2018SAFEPEDRUG\u2019 project (IWT\/SBO 130033). Jens Peter N\u00f8rgaard is supported by a Ferring Grant (Guest professor).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Elke Gasthuys, Lien Dossche, Robin Michelet, Jens Peter N\u00f8rgaard, Mathias Devreese, Siska Croubels, An Vermeulen, Jan Van Bocxlaer and Johan Vande Walle declare that they have no conflict of interest related to the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Data sharing not applicable to this article since no datasets were generated or analyzed during the current study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}}]}}